These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 34920070)
1. MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila. Zhang L; Wang Y; Wu F; Wang X; Feng Y; Wang Y Int J Biol Macromol; 2022 Jan; 196():23-34. PubMed ID: 34920070 [TBL] [Abstract][Full Text] [Related]
2. MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis. Wang X; Shi L; Wang X; Feng Y; Wang Y Int J Biol Macromol; 2019 Dec; 141():1013-1021. PubMed ID: 31491513 [TBL] [Abstract][Full Text] [Related]
3. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota. Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192 [TBL] [Abstract][Full Text] [Related]
4. MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice. Shi LL; Li Y; Wang Y; Feng Y Int J Biol Macromol; 2015 Nov; 81():576-83. PubMed ID: 26321425 [TBL] [Abstract][Full Text] [Related]
5. Increase of Nishiyama M; Ohtake N; Kaneko A; Tsuchiya N; Imamura S; Iizuka S; Ishizawa S; Nishi A; Yamamoto M; Taketomi A; Kono T Nutrients; 2020 Mar; 12(3):. PubMed ID: 32245128 [TBL] [Abstract][Full Text] [Related]
6. Multiomics reveals the ameliorating effect and underlying mechanism of aqueous extracts of polygonatum sibiricum rhizome on obesity and liver fat accumulation in high-fat diet-fed mice. Ou X; Chen J; Li B; Yang Y; Liu X; Xu Z; Xiang X; Wang Q Phytomedicine; 2024 Sep; 132():155843. PubMed ID: 38971026 [TBL] [Abstract][Full Text] [Related]
7. MDG-1, a polysaccharide from Ophiopogon japonicus, prevents high fat diet-induced obesity and increases energy expenditure in mice. Wang Y; Zhu Y; Ruan K; Wei H; Feng Y Carbohydr Polym; 2014 Dec; 114():183-189. PubMed ID: 25263880 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642 [TBL] [Abstract][Full Text] [Related]
9. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis. Wang P; Wang J; Li D; Ke W; Chen F; Hu X J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250 [TBL] [Abstract][Full Text] [Related]
10. Akkermansia muciniphila: A potential novel mechanism of nuciferine to improve hyperlipidemia. Yu Y; Lu J; Sun L; Lyu X; Chang XY; Mi X; Hu MG; Wu C; Chen X Biomed Pharmacother; 2021 Jan; 133():111014. PubMed ID: 33246225 [TBL] [Abstract][Full Text] [Related]
11. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice. Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920 [TBL] [Abstract][Full Text] [Related]
12. Cilostazol Attenuates Hepatic Steatosis and Intestinal Disorders in Nonalcoholic Fatty Liver Disease. Min T; Qiu S; Bai Y; Cao H; Guo J; Su Z Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892467 [TBL] [Abstract][Full Text] [Related]
14. MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids. Shi L; Wang J; Wang Y; Feng Y Carbohydr Polym; 2016 Oct; 150():74-81. PubMed ID: 27312615 [TBL] [Abstract][Full Text] [Related]
15. Combination of Probiotics and Wang W; Xu AL; Li ZC; Li Y; Xu SF; Sang HC; Zhi F Diabetes Metab J; 2020 Apr; 44(2):336-348. PubMed ID: 31950772 [TBL] [Abstract][Full Text] [Related]
16. Exploring the Regulatory Effect of Tegillarca granosa Polysaccharide on High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice Based on Intestinal Flora. Yang X; Yao S; Jiang Q; Chen H; Liu S; Shen G; Xiang X; Chen L Mol Nutr Food Res; 2024 Jul; 68(14):e2300453. PubMed ID: 38389187 [TBL] [Abstract][Full Text] [Related]
17. Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice. Qian M; Lyu Q; Liu Y; Hu H; Wang S; Pan C; Duan X; Gao Y; Qi LW; Liu W; Wang L Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31269758 [TBL] [Abstract][Full Text] [Related]
18. The protective effects of walnut green husk polysaccharide on liver injury, vascular endothelial dysfunction and disorder of gut microbiota in high fructose-induced mice. Wang G; Zhang Y; Zhang R; Pan J; Qi D; Wang J; Yang X Int J Biol Macromol; 2020 Nov; 162():92-106. PubMed ID: 32531370 [TBL] [Abstract][Full Text] [Related]
19. Fecal metabonomic study of a polysaccharide, MDG-1 from Ophiopogon japonicus on diabetic mice based on gas chromatography/time-of-flight mass spectrometry (GC TOF/MS). Zhu Y; Cong W; Shen L; Wei H; Wang Y; Wang L; Ruan K; Wu F; Feng Y Mol Biosyst; 2014 Feb; 10(2):304-12. PubMed ID: 24292023 [TBL] [Abstract][Full Text] [Related]
20. Soluble Polysaccharide Derived from Zhang Y; Yang L; Zhao N; Hong Z; Cai B; Le Q; Yang T; Shi L; He J Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]